ThermoGenesis Corporation, a wholly owned subsidiary of Cesca Therapeutics, is a pioneer and market leader in the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The division’s automated functionally-closed cell processing and cryopreservation systems provide researchers, physicians and cell-based manufacturers with solutions for Clinical Biobanking, Point-of-Care and Immuno-Oncology.